Q32 Bio to Participate in Upcoming September Investor Conferences
Management will join three investor events, including a Jefferies fireside chat and 1:1 meetings, with some sessions available by webcast.
- Numerous biotechnology and industrial firms, including Rocket Pharmaceuticals and Q32 Bio, will participate in high-profile investor conferences throughout September 2026, providing management teams critical platforms to communicate clinical developments to global investors.
- Companies are leveraging these forums to detail advancements in gene editing and industrial automation, aiming to bridge the gap between scientific innovation and commercial viability through leadership presentations.
- Rocket Chief Executive Officer Gaurav Shah will participate in the 2026 Cantor Global Healthcare Conference on September 10, while Gates Industrial Corporation leaders present at the Jefferies Global Industrials Conference on Wednesday, September 9.
- Investors unable to attend in person can access live audio webcasts through companies' respective websites, with most events offering archived replays for 30 days following each presentation.
- Beyond these September gatherings, IDEAYA Biosciences is scheduling an investor R&D day in London on Monday, November 16th, highlighting continued focus on addressing complex medical challenges through personalized therapeutic research strategies.
26 Articles
26 Articles
Herald & Review
stocktitan.netTETRA TECHNOLOGIES, INC. TO PARTICIPATE IN UPCOMING INVESTOR CONFERENCES
SPRING, Texas, Sept. 2, 2026 /PRNewswire/ -- TETRA Technologies, Inc. ("TETRA" or the "Company") (NYSE: TTI) announced that Brady Murphy, Chief Executive Officer, and Kurt Hallead, Treasurer and VP of Investor Relations, will be meeting with institutional investors at the…
Morgan County Citizen
inovio.comINOVIO to Participate in Upcoming Investor Conferences
PLYMOUTH MEETING, Pa., Sept. 1, 2026 /PRNewswire/ -- INOVIO (NASDAQ:INO), a biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from HPV-related diseases, cancer and infectious diseases, today announced that it will participate in…
ARS Pharmaceuticals to Participate in Upcoming Investor Conferences
SAN DIEGO, Sept. 01, 2026 (GLOBE NEWSWIRE) -- ARS Pharmaceuticals, Inc. (Nasdaq: SPRY), a biopharmaceutical company dedicated to empowering at-risk patients and their caregivers to treat and prevent severe allergic reactions, today announced that Donn Casale, President and CEO, will…
North Bay Nipissing
Financial PostProMIS Neurosciences to Participate in Upcoming Conferences and Events in September
CAMBRIDGE, Mass, Sept. 01, 2026 (GLOBE NEWSWIRE) -- ProMIS Neurosciences Inc. (Nasdaq: PMN), a clinical-stage biotechnology company developing antibody therapeutics and vaccines targeting toxic misfolded proteins in neurodegenerative diseases, today announced that it will participate in upcoming September 2026 conferences…
Coverage Details
Bias Distribution
- 68% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
